Australian device maker strikes partnership with the U.S. Oncology Network
Impedimed, which is headquartered in Australia, makes a tool for early detection of lymphedema in cancer patients.
Impedimed, which is headquartered in Australia, makes a tool for early detection of lymphedema in cancer patients.
The insurer said it will provide compensation for better care navigation based on quality and cost metrics across various parts of the patient journey ranging from inpatient admissions, ED visits, prescription drugs, diagnostics and radiology.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.